Radiopharmaceutical Production

Slides:



Advertisements
Similar presentations
NUCP 2371 Radiation Measurements II
Advertisements

Analytical Method Development and Validation
Instrumental Analysis
Gamma-Ray Spectra _ + The photomultiplier records the (UV) light emitted during electronic recombination in the scintillator. Therefore, the spectrum collected.
CHEMISTRY ANALYTICAL CHEMISTRY Fall
Microspectrophotometry Validation. Reasons for Changing Instruments Reduced reliability. Limited efficiency. Limited availability and cost of replacement.
Radiopharmaceutical Production
World Health Organization
Screening of Urine Bioassay Samples using a Standard Nuclear Medicine Gamma Camera Chris Martel Director, RSO Brigham & Women’s Hospital Associate in Radiology.
Other Univariate Statistical Process Monitoring and Control Techniques
Planar scintigraphy produces two-dimensional images of three dimensional objects. It is handicapped by the superposition of active and nonactive layers.
QUALITY CONTROL OF PHYSICO-Chemical METHODS Introduction :Validation توثيق المصدوقية.
Kyiv, TRAINING WORKSHOP ON PHARMACEUTICAL QUALITY, GOOD MANUFACTURING PRACTICE & BIOEQUIVALENCE Validation of Analytical Methods Used For Bioequivalence.
Radiopharmaceutical Production
Validation of Analytical Method
Audit Sampling 1.
Analytical considerations
Unit 1 Accuracy & Precision.  Data (Singular: datum or “a data point”): The information collected in an experiment. Can be numbers (quantitative) or.
Accurate gamma-ray spectrometry of environmental samples: a challenge O. Sima - Bucharest University D. Arnold - PTB Braunschweig C. Dovlete - ERL Bucharest.
Aloe Vera of America: A Quality IASC-Certified Producer of Aloe Vera Presented by Walt Jones.
Radiopharmaceutical Production Quality Control Testing Product Stability STOP.
Radiopharmaceutical Production Sub STOP. Radionuclidic purity Radionuclidic purity may be defined as the fraction of total radioactivity that is present.
Radioactive Decay Quick Review Atom made of 3 subatomic particles Protons (positive, inside nucleus) Protons (positive, inside nucleus) Electrons (negative,
Introduction to nuclear medicine technology NMT 231 Aya Ahmed Saeed.
Chapter 29:Nuclear Physics
Validation Defination Establishing documentary evidence which provides a high degree of assurance that specification process will consistently produce.
Radiopharmaceutical Production Radionuclidic identity STOP.
Radiopharmaceutical Production
Radiopharmaceutical Production Radioassay STOP. Radiopharmaceutical Production Radioassay Example STOP Radioassay Acceptance Criteria: The product label.
SEMINAR ON PRESENTED BY BRAHMABHATT BANSARI K. M. PHARM PART DEPARTMENT OF PHARMACEUTICS AND PHARMACEUTICAL TECHNOLGY L. M. COLLEGE OF PHARMACY.
이 장 우. 1. Introduction  HPLC-MS/MS methodology achieved its preferred status -Highly selective and effectively eliminated interference -Without.
Chapter-5 Positron emission tomography (PET)
ICARUS T600: low energy electrons
5.5 Medical Applications Using Radioactivity
Investigation of the proton-induced reactions on natural molybdenum.
Radiopharmaceutical Production
Chemistry Nuclear Chemistry.
Chapter 9 Audit Sampling 1.
Chapter 29:Nuclear Physics
Objectives To learn the types of radioactive decay
Image quality and Performance Characteristics
What is an isotope? Agenda for Tuesday Feb 8th Percent composition
DAMA Calibrations – low energy
Nuclear Chemistry.
CLRS 321 Nuclear Medicine Physics & Instrumentation I
Chance and Randomness Random: Having no definite aim or purpose; not sent or guided in a particular direction; made, done, occurring, etc., without method.
Sophie Lancelot, Luc Zimmer  Trends in Pharmacological Sciences 
Nuclear Chemistry.
Analytical Method Validation
Algorithm An algorithm is a finite set of steps required to solve a problem. An algorithm must have following properties: Input: An algorithm must have.
Nuclear Chemistry Chapter 9.
Introduction to Radioactivity and the 3 types of Nuclear Radiation
Radioactivity Nuclei that are unstable decay; many such decays are governed by another force called the weak nuclear force. Radioactive rays were observed.
Nuclear Changes Chapter 9.
Counting Statistics and Error Prediction
Yields of Gamma Radiation of 235U
Calculating Uncertainties Using Data from precision & bias experiments
Function and Structure in
Recent check of calibration across detectors
CHAPTER – 1.1 UNCERTAINTIES IN MEASUREMENTS.
Nuclear Reactions.
Radiochemical Methods
CHAPTER 22 Nuclear Chemistry
Nuclear Chemistry The energy of life.
Radiopharmaceutical Production
Chapter 21 Section 1 – The Nucleus Nuclear Chemistry.
DETERMINATION OF AN ENVIRONMENTAL BACKGROUND SPECTRUM AND DATA TO BE USED FOR ROUTINE ANALYSES OF WHOLE BODY COUNTS F BEESLAAR.
Radioactivity GEOG/PHYS 182.
Objectives To learn the types of radioactive decay
Presentation transcript:

Radiopharmaceutical Production Radionuclidic identity STOP

Radionuclidic identity The radionuclidic identity and purity tests show that the radiopharmaceutical does not contain radionculides other than the one desired. Contents Requirements Discussion Procedure

Requirements Requirement: The measured physical half-life of the test sample must be between 105 and 115 minutes. The test should be completed prior to release of product. The gamma spectrum of the test sample should show the major peak at 511 KeV, and a sum peak at 1022 KeV depending on geometry and detector efficiency. Not less than 99% of the gamma emissions should correspond to 18F. This test should be performed periodically.

Discussion Discussion: Half-life: Half life can be determined within the acceptable limits using counting equipment, such as dose calibrator or a well counter by measuring radioactivity of the test sample at two or more time points, and the decay calculations. In practical consideration for the short half-life of 18F and need to release the product the soonest, a precisely measured counting time of at least 10 minutes is generally sufficient to determine the physical half-life of 18F. The measured half life will be lower if 13N impurity is present in FDG. During validation studies, the time interval between measurements may be increased for improved assurance of radionuclidic purity. Gamma Spectrum: It must be realized that the mere presence of 511 KeV or 1022 KeV peak in γ-ray spectrum is not sufficient to determine radionuclidic identity. Impurity such as 13N (arising from 16O impurity in the target) and/or other positron emitters will not be detected as the gamma peaks with energy of 511 KeV and 1022 KeV sum peak are a common feature of positron emitters. Therefore, a combination of gamma spectrum and the half-life measurement together provide the best assurance of radionuclidic identity and purity.

Half-Life Procedure Procedure: For half-life measurement, place a small aliquot of the test sample in a dose calibrator or in a well counter. Record the initial radioactivity (A0). Record the radioactivity again after at least 10 minutes (measured precisely) (A10). Calculate the half- life from the two measured values as per the formula: T1/2 = 0.693 x t / [2.03 x [Log A0-Log A10]: where T1/2 and t are in minutes. Record the gamma spectrum (NaI or HPGe) of a test sample that has been diluted appropriately (and quantitatively) to provide optimum number of counts.

Half-Life Procedure Demonstration Procedure – In this demonstration, the test is done using a well counter and software written to calculate the half-life. A sample taken from the final product containing between 10,000 – 300,000 cpm. This particular program will record the number of counts in the sample 100 times, and run an algorithm that determines the half-life of the sample. It reports the half-life and the percent deviation. Half-life Values If the half-life values are not within the range specified in the Table, a common cause is that the amount radionuclide used was too high or too low, so this should be taken into account when repeating the determination. As an example, if the analysis gives an incorrect half-life, the amount of fluorine-18 sample should be reduced by a factor of 5 and the test repeated Radionuclide Half-life Acceptance Range Nitrogen-13 9 – 11 min Carbon-11 18 - 22 min Fluorine-18 105 - 115 min Demonstration

Return to Main Menu